Umbilical Cord-Derived Mesenchymal Stem Cell Transplantation in Hepatitis B Virus Related Acute-on-Chronic Liver Failure Treated with Plasma Exchange and Entecavir: a 24-Month Prospective Study (Q40559507)

From Wikidata

Jump to navigation Jump to search

scientific article published on 29 September 2016

Language	Label	Description	Also known as
English	Umbilical Cord-Derived Mesenchymal Stem Cell Transplantation in Hepatitis B Virus Related Acute-on-Chronic Liver Failure Treated with Plasma Exchange and Entecavir: a 24-Month Prospective Study	scientific article published on 29 September 2016

Statements

scholarly article

1 reference

Europe PubMed Central

21 September 2017

Umbilical Cord-Derived Mesenchymal Stem Cell Transplantation in Hepatitis B Virus Related Acute-on-Chronic Liver Failure Treated with Plasma Exchange and Entecavir: a 24-Month Prospective Study (English)

1 reference

Europe PubMed Central

21 September 2017

Hepatitis B virus

1 reference

based on heuristic

inferred from title

umbilical cord mesenchymal stem cell

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Yu-Hua Li

1

1 reference

Europe PubMed Central

21 September 2017

Ying Xu

2

1 reference

Europe PubMed Central

21 September 2017

Hua-Mei Wu

3

1 reference

Europe PubMed Central

21 September 2017

Jing Yang

4

1 reference

Europe PubMed Central

21 September 2017

Li-Hong Yang

5

1 reference

Europe PubMed Central

21 September 2017

Wan Yue-Meng

6

1 reference

Europe PubMed Central

21 September 2017

publication date

29 September 2016

1 reference

Europe PubMed Central

21 September 2017

Stem Cell Reviews and Reports

1 reference

Europe PubMed Central

21 September 2017

12

1 reference

Europe PubMed Central

21 September 2017

645-653

1 reference

Europe PubMed Central

21 September 2017

6

1 reference

Europe PubMed Central

21 September 2017

https://scigraph.springernature.com/pub.10.1007/s12015-016-9683-3

0 references

Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL) 2014.

1 reference

https://api.crossref.org/works/10.1007%2FS12015-016-9683-3

21 January 2018

Liver dialysis in acute-on-chronic liver failure: current and future perspectives.

1 reference

https://api.crossref.org/works/10.1007%2FS12015-016-9683-3

21 January 2018

High-volume plasma exchange in patients with acute liver failure: An open randomised controlled trial

1 reference

https://api.crossref.org/works/10.1007%2FS12015-016-9683-3

21 January 2018

The effect of plasma exchange on entecavir-treated chronic hepatitis B patients with hepatic de-compensation and acute-on-chronic liver failure

1 reference

https://api.crossref.org/works/10.1007%2FS12015-016-9683-3

21 January 2018

In vitro hepatic differentiation of human mesenchymal stem cells

1 reference

https://api.crossref.org/works/10.1007%2FS12015-016-9683-3

21 January 2018

Improved liver function in patients with liver cirrhosis after autologous bone marrow cell infusion therapy

1 reference

https://api.crossref.org/works/10.1007%2FS12015-016-9683-3

21 January 2018

Improvement of liver function in liver cirrhosis patients after autologous mesenchymal stem cell injection: a phase I-II clinical trial.

1 reference

https://api.crossref.org/works/10.1007%2FS12015-016-9683-3

21 January 2018

Human mesenchymal stem cell transfusion is safe and improves liver function in acute-on-chronic liver failure patients

1 reference

https://api.crossref.org/works/10.1007%2FS12015-016-9683-3

21 January 2018

Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the study of the liver (APASL).

1 reference

https://api.crossref.org/works/10.1007%2FS12015-016-9683-3

21 January 2018

The model for end-stage liver disease (MELD)

1 reference

https://api.crossref.org/works/10.1007%2FS12015-016-9683-3

21 January 2018

Flares in chronic hepatitis B patients induced by the host or the virus? Relation to treatment response during Peg-interferon {alpha}-2b therapy

1 reference

https://api.crossref.org/works/10.1007%2FS12015-016-9683-3

21 January 2018

Effects of nucleoside analogue on patients with chronic hepatitis B-associated liver failure: meta-analysis

1 reference

https://api.crossref.org/works/10.1007%2FS12015-016-9683-3

21 January 2018

A comparison of entecavir and lamivudine for HBeAg-positive chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1007%2FS12015-016-9683-3

21 January 2018

Entecavir versus lamivudine for patients with HBeAg-negative chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1007%2FS12015-016-9683-3

21 January 2018

Long-term monitoring shows hepatitis B virus resistance to entecavir in nucleoside-naïve patients is rare through 5 years of therapy

1 reference

https://api.crossref.org/works/10.1007%2FS12015-016-9683-3

21 January 2018

Severe lactic acidosis during treatment of chronic hepatitis B with entecavir in patients with impaired liver function

1 reference

https://api.crossref.org/works/10.1007%2FS12015-016-9683-3

21 January 2018

Advanced therapeutic strategies for HBV-related acute-on-chronic liver failure

1 reference

https://api.crossref.org/works/10.1007%2FS12015-016-9683-3

21 January 2018

Clinical therapeutic effects of human umbilical cord-derived mesenchymal stem cells transplantation in the treatment of end-stage liver disease

1 reference

https://api.crossref.org/works/10.1007%2FS12015-016-9683-3

21 January 2018

Effects of transplanted bone-marrow-derived mesenchymal stem cells in animal models of acute hepatitis

1 reference

https://api.crossref.org/works/10.1007%2FS12015-016-9683-3

21 January 2018

Immunomodulatory properties and therapeutic application of mesenchymal stem cells

1 reference

https://api.crossref.org/works/10.1007%2FS12015-016-9683-3

21 January 2018

Functional integration of hepatocytes derived from human mesenchymal stem cells into mouse livers.

1 reference

https://api.crossref.org/works/10.1007%2FS12015-016-9683-3

21 January 2018

Fibrogenic potential of human multipotent mesenchymal stromal cells in injured liver

1 reference

https://api.crossref.org/works/10.1007%2FS12015-016-9683-3

21 January 2018

Hepatocyte differentiation of mesenchymal stem cells from human adipose tissue in vitro promotes hepatic integration in vivo.

1 reference

https://api.crossref.org/works/10.1007%2FS12015-016-9683-3

21 January 2018

Acute-on-Chronic Liver Failure Is a Distinct Syndrome That Develops in Patients With Acute Decompensation of Cirrhosis

1 reference

https://api.crossref.org/works/10.1007%2FS12015-016-9683-3

21 January 2018

Autologous bone marrow mesenchymal stem cell transplantation in liver failure patients caused by hepatitis B: short-term and long-term outcomes

1 reference

https://pubmed.ncbi.nlm.nih.gov/27687792

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Human umbilical cord mesenchymal stem cells improve liver function and ascites in decompensated liver cirrhosis patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/27687792

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Artificial and bioartificial liver support systems for acute and acute-on-chronic hepatic failure: A meta-analysis and meta-regression

1 reference

https://pubmed.ncbi.nlm.nih.gov/27687792

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Telbivudine versus lamivudine and entecavir for treatment-naïve decompensated hepatitis B virus-related cirrhosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/27687792

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

AASLD practice guidelines: Evaluation of the patient for liver transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/27687792

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Isolation and characterization of human umbilical cord mesenchymal stem cells with hematopoiesis-supportive function and other potentials.

1 reference

https://pubmed.ncbi.nlm.nih.gov/27687792

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Granulocyte colony-stimulating factor mobilizes CD34(+) cells and improves survival of patients with acute-on-chronic liver failure

1 reference

https://pubmed.ncbi.nlm.nih.gov/27687792

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of plasma exchange on serum tissue inhibitor of metalloproteinase 1 and cytokine concentrations in patients with fulminant hepatitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/27687792

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Human mesenchymal stem cells as a two-edged sword in hepatic regenerative medicine: engraftment and hepatocyte differentiation versus profibrogenic potential

1 reference

https://pubmed.ncbi.nlm.nih.gov/27687792

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Are proinflammatory cytokine concentrations reduced by plasma exchange in patients with severe acute hepatic failure?

1 reference

https://pubmed.ncbi.nlm.nih.gov/27687792

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A study on the sero-epidemiology of hepatitis B in Chinese population aged over 3-years old

1 reference

https://pubmed.ncbi.nlm.nih.gov/27687792

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S12015-016-9683-3

1 reference

Europe PubMed Central

21 September 2017

1 reference

Europe PubMed Central

21 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40559507&oldid=1900558804"